CClinicalTrials.gg
Status unknownNCT03318185Updated Jan 12, 2018

Gasless Single-port Laparoscopic-assisted Radical Resection for Rectal Carcinoma

An interventional study of gasless single-port laparoscopic surgery and conventional laparoscopic surgery in Laparoscopic Surgery, sponsored by The Second Affiliated Hospital of Chongqing Medical University. Status unknown at 1 site in China. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2018-01-12.

Sponsored by The Second Affiliated Hospital of Chongqing Medical University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jan 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

This project aims to investigate the safety and effectiveness of gasless single-port laparoscopic-assisted radical resection (GSLR) in the treatment of rectal carcinoma.

Read the detailed description

The gasless single-port laparoscopic-assisted surgery (GSLS) is associated with rapid recovery and shorter postoperative hospital stay and no pneumoperitoneum complications occur after the operation. To our knowledge, there have been no reports about GSLS applied to the treatment of gastrointestinal cancer in the world. To explore the safety and effectiveness of GSLS in rectal cancer patients, this project plans to evaluate the operation time, cardio-pulmonary function, postoperative pain, immunologic function and restoration of bowel function after the operation.

02

Conditions studied

  • Laparoscopic Surgery

Browse trials for

Keywords

  • gasless single-port laparoscopic surgery;rectal carcinoma
03

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Rectal carcinoma;The distance between tumor and anal verge is 5-15cm; The primary tumor can radical resect.

Exclusion criteria

Exclusion Criteria:

  • Neoadjuvant therapy;Surgical contraindication.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    gasless single-port laparoscopic surgery

    radical resection of rectal carcinoma is performed by gasless single-port laparoscopic-assisted surgery.

    Procedure: gasless single-port laparoscopic surgery

  • Sham comparator
    conventional laparoscopic surgery

    radical resection of rectal carcinoma is performed by conventional laparoscopic surgery.

    Procedure: conventional laparoscopic surgery

Interventions

  • Proceduregasless single-port laparoscopic surgery

    The single-port laparoscopic surgery is performed when the maneuvering room is provided by external suspension system.

  • Procedureconventional laparoscopic surgery

    The multi-port laparoscopic surgery is performed when the belly is inflated with carbon dioxide to provide maneuvering room.

05

What researchers measure

Primary outcomes

  1. Pulmonary function

    Estimate the pulmonary function in the perioperational period by blood gas analysis, which will be compared with comparator.The main parameter partial pressure of oxygen(PaO2)/inspired oxygen fraction(FiO2) ratio is the ratio of arterial oxygen partial pressure to fractional inspired oxygen.

    Time frame: Change from baseline PaO2/FiO2 ratio 10 minutes after the surgery is over.

  2. Immunologic function

    Estimate the immunologic function in the perioperational period by blood lymphocyte analysis, which will be compared with comparator.The main parameter cluster of differentiation 4(CD4)/cluster of differentiation 8(CD8) ratio is the ratio of lymphocyte CD4 numbers to lymphocyte CD8 numbers.

    Time frame: Change from baseline CD4/CD8 ratio 7 days after operation.

Secondary outcomes

  1. Operation time

    Measure the operation time, which will be compared with comparator.

    Time frame: at 1 day

  2. Postoperative pain

    Measure the postoperative pain after operation by numerical rating scale(NRS), which will be compared with comparator.

    Time frame: 72 hours after operation

  3. Bowel function

    Measure the restoration of bowel function after operation, which will be compared with comparator.The bowel function was evaluated by first flatus.

    Time frame: up to 1 week after operation

  4. Number of the lymph node dissection

    Measure the number of the regional lymph node dissection after operation, which will be compared with comparator.

    Time frame: at 1 week after operation

06

Study locations

1 of 1 sites recruiting
  • Gastrointestinal Surgery Department of the Second Affiliated Hospital of Chongqing Medical University
    Chongqing, Chongqing, China
    Recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03318185
Lead sponsor
The Second Affiliated Hospital of Chongqing Medical University
Responsible party
Sponsor
First posted
Oct 23, 2017
Start date
Nov 1, 2017
Primary completion
Nov 1, 2019 (estimated)
Completion
Sep 1, 2020 (estimated)
Last update
Jan 12, 2018

Study contacts

Jijian Wang, phD
Contact
wangjj1963@163.com
02363693511
Jianbo Zhang, phD
Contact
172329491@qq.com
02363693510
Jijian Wang, phD
study chair · The Second Affiliated Hospital of Chongqing Medical University
Yaxu Wang, phD
principal investigator · The Second Affiliated Hospital of Chongqing Medical University
Yang Li, phD
principal investigator · The Second Affiliated Hospital of Chongqing Medical University
Daihua Zhu, phD
principal investigator · The Second Affiliated Hospital of Chongqing Medical University
Jianbo Zhang, phD
principal investigator · The Second Affiliated Hospital of Chongqing Medical University
Haitao Gu, phD
principal investigator · The Second Affiliated Hospital of Chongqing Medical University
Shiji Zhou, phD
principal investigator · The Second Affiliated Hospital of Chongqing Medical University
Zhiquan Xu, Bachelor
principal investigator · The Second Affiliated Hospital of Chongqing Medical University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion